The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Hikma Pharmaceuticals competitive analysis

Loading summary...

Latest PTAB cases involving Hikma Pharmaceuticals

Discover the latest PTAB cases involving Hikma Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Last updated on: Nov 13, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Hikma Pharmaceuticals

IPR2024-01418Sep 25, 2024HIKMA PHARMACEUTICALS USAAXSOME MALTATerminated-Settled
IPR2022-00215Nov 30, 2021HIKMA PHARMACEUTICALS USAAMARIN PHARMACEUTICALS IRELANDTerminated-Settled
IPR2018-00507Jan 17, 2018HIKMA PHARMACEUTICALSNOVARTIS PHARMACEUTICALSTerminated-Settled

Peer Comparison New

IP litigation analysis comparing Hikma Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
HIKMA PHARMACEUTICALS USA - - 2 -
AMARIN PHARMACEUTICALS IRELAND - 15 - 1
AXSOME MALTA - 3 - 1